Now a Virtual Experience: 2020 ISPE Europe Annual Conference 

Professional development and knowledge exchange in the pharmaceutical industry are more critical now than ever before, as the COVID-19 pandemic continues to have an unforeseeable global impact. It is essential to keep knowledge thriving to help drive the pharmaceutical industry forward and enhance patient health and safety worldwide.  

We are pleased to announce that we are transforming Europe’s most comprehensive event on the latest innovations in pharmaceutical manufacturing to be fully digital: the 2020 ISPE Europe Annual Virtual Conference, taking place on 16–17 September 2020. As a bonus, delegates will receive access to the recording of all conference sessions for one year. 

In addition to new content focused on industry response and issues associated with the COVID-19 pandemic, delegates will still benefit from robust, content-rich, interactive sessions covering critical topics like digitisation, the FDA’s continuous manufacturing draft guidance, aseptic processing, Annex 1, small molecules, and more. 

It's our priority to make this the best and most informative ISPE Europe Annual Virtual Conference to date, and we remain excited to host you in September. We will update the event page in the coming weeks with additional information. 


COVID-19 and After: Impact on Innovation, Production, Quality and Supply Chain

The 2020 ISPE Europe Annual Virtual Conference has four tracks focusing on:

  • Track 1: Facilities of the Future - Continuous manufacturing for oral solids and biotech; aseptic processing new improvements and technical innovations
  • Track 2: Pharma 4.0 – what is the way to implement the new operating model with industry cases, application of maturity models, digitisation, self-learning devices, plug and produce and a holistic control strategy
  • Track 3: Quality - validation, Annex 1, Annex 2, ICH Q13 and the FDA’s continuous manufacturing draft guidance, Annex 17 real time release testing and continuous verification
  • Track 4: New Trends in CQV and Impact on Project Delivery – small molecules, API, biopharmaceutical operations, key controls for being more flexible, more agile, more adaptive to changing product portfolio

Why Attend Virtually

  • Feel like You're In-Person with a Fully Interactive Digital Experience
    Our event portal is easy to navigate and will allow you to view presentations, access PDFs of the presentations, take downloadable notes in each session, participate in polls, chat with other attendees, and participate in LIVE Q&A sessions with speakers.
    alt 1
  • Build Your Experience
    Add the sessions you want to attend with the click of a button to build your own custom agenda. Interested in two sessions happening at the same? We have you covered because you'll have access to all of the recordings from the event for one year.
    alt 2
  • Gain Actionable Insights
    Global experts will be at your fingertips sharing their knowledge and lessons learned on advanced therapeutic medicinal products (ATMPs) including cell and gene therapies, digitalization, single-use technology, implications of ICH Q12 for biopharma, and much more.
    alt 3
  • Stay Current and Knowledgeable Throughout the Year
    In addition to expert insights, your tangible takeaways include access to the recording of ALL conference sessions and presentations for one year. Unlike an in-person event, you’ll get to experience the sessions you missed—that means both tracks! The recordings are also valuable as a refresher throughout the year.
    alt  4

Virtual Event FAQs


Who Should Attend?

Professionals at all levels of the pharmaceutical industry including:

Young Professionals Senior Executives Communities of Practice Special Interest Groups Equipment and Services Suppliers Regulatory Professionals